• Nenhum resultado encontrado

Rev. Bras. Anestesiol. vol.66 número6

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Anestesiol. vol.66 número6"

Copied!
6
0
0

Texto

(1)

REVISTA

BRASILEIRA

DE

ANESTESIOLOGIA

PublicaçãoOficialdaSociedadeBrasileiradeAnestesiologia

www.sba.com.br

SCIENTIFIC

ARTICLE

Sufentanil

in

combination

with

low-dose

hyperbaric

bupivacaine

in

spinal

anesthesia

for

cesarean

section:

a

randomized

clinical

trial

Alexandre

Dubeux

Dourado

a

,

Ruy

Leite

de

Melo

Lins

Filho

a

,

Raphaella

Amanda

Maria

Leite

Fernandes

a,∗

,

Marcelo

Cavalcanti

de

Gondim

a

,

Emmanuel

Victor

Magalhães

Nogueira

b

aUniversidadeFederaldePernambuco(UFPE),HospitaldasClínicas,Recife,PE,Brazil

bUniversidadeFederaldePernambuco(UFPE),HospitaldasClínicas,ProgramadeResidênciaMédicaemAnestesiologia,

Recife,PE,Brazil

Received4April2015;accepted12May2015 Availableonline13September2016

KEYWORDS

Sufentanil; Spinalanesthesia; Bupivacaine; Hyperbaric; Cesareansection

Abstract Adoubleblindrandomizedclinicaltrialofsufentanilasanadjunctinspinal anes-thesiaforcesareansectionand,thereby,beabletoreducethedoseofbupivacaine,alocal anesthetic, with the same result of ananesthetic block with higher doses but with fewer perioperativesideeffects,suchashypotension.

©2016SociedadeBrasileiradeAnestesiologia.PublishedbyElsevierEditoraLtda.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/).

PALAVRAS-CHAVE

Sufentanil; Raquianestesia; Bupivacaína; Hiperbárica; Cesariana

Associac¸ãodesufentaniladosereduzidadebupivacaínahiperbárica emraquianestesiaparacesariana:ensaioclínicorandomizado

Resumo Ensaioclínico randomizadoduplamenteencobertosobreousodosufentanilcomo adjuvanteemraquianestesiaparacesarianae,possibilitandoareduc¸ãodadosedoanestésico local,abupivacaína,comomesmoresultadodebloqueioanestésicocomdosesmaiselevadas, mascommenosefeitoscolateraisnoperioperatório,comohipotensão.

©2016SociedadeBrasileiradeAnestesiologia.PublicadoporElsevierEditoraLtda.Este ´eum artigoOpen Accesssobumalicenc¸aCCBY-NC-ND( http://creativecommons.org/licenses/by-nc-nd/4.0/).

Correspondingauthor.

E-mail:rafa.amanda120@gmail.com(R.A.Fernandes).

http://dx.doi.org/10.1016/j.bjane.2015.05.002

(2)

Introduction

Compared togeneral anesthesia, neuraxial anesthesiafor

cesarean section (C-section)presents advantages, suchas

reduced risk of intubation failure and aspiration of

gas-tric contents, reduced use of depressants (hypnotics and

opioids),andthemother’sconsciousnessthatallows

moth-ers undergo the birth experience.1,2 Spinal anesthesia is

currently the most widely used technique for C-section,

asit providesintensesensoryblockandrapidinstallation.

However,thistechniquecanbeaccompaniedbysignificant

hypotension,itsmostimportantsideeffect,withreported

incidenceof20---100%.3---5

Several strategies have been described to prevent the

occurrenceofhypotensioninC-section,suchasleftuterine

displacement, crystalloid or colloid administration, lower

limb wrapping, prophylacticuse of ephedrineor

phenyle-phrine,butnoneofthemeliminatedhypotension.6,7

Therelationshipbetweenthelocalanesthetic(LA)dose

used and the occurrence of maternal hypotension is well

established,withhigherdosesrelatedtoahigherincidence

ofhypotension.8However,thereductionofLAdoseleadsto

increasedincidenceofintraoperativepain.3,9

Ithasbeenshownthatthecombinationoflipophilic

opi-oids with local anesthetics in spinal anesthesiaallows LA

dosereductionandpromoteseffectiveanesthesiawithless

sideeffectsonmaternalhemodynamics.10---14

Sufentanil,highlysoluble,enhancesanalgesiaand

com-fortduringsurgery,withashortlatencyperiod(5---10min) anddurationofactionofupto7h.10,15---17The useof

mor-phine, soluble opioid, is recommended to ensure longer

postoperativeanalgesia.10,18

The aim of this study wasto compare the efficacy of

anesthesiaandtheincidenceof sideeffects betweentwo

hyperbaric bupivacaine doses in spinal anesthesia for

C-sectionwithcombinedsufentanilatthelowestdose.

Material

and

methods

After approval by the Ethics Committee, the

random-ized double-blind trial was started with 94 women,

aged 18---45 years, undergoing C-section under spinal

anesthesia. After obtaining written informed consent

and consulting the randomization table, patients were

allocated to one of two study groups: Group A

(bupiva-caine 12.5mg+morphine 80␮g)and Group S (bupivacaine

10mg+morphine80␮g+sufentanil5␮g).Syringes

prepara-tionandspinalanesthesiaadministrationwereperformedby

ananesthesiologistblindedtodatacollection.Allthe inves-tigatorsinvolvedinthestudywereblindedtotheassignment

ofeach group.Pregnantwomenunabletodecideontheir

participationinthe studyor unabletoprovidethe

neces-saryinformation,ASAIVorV,requiringemergencyobstetric

care,withahistoryofhypersensitivityorallergytoanyof

thestudydrugs,andthosewithanycontraindicationtothe

techniqueproposedwereexcluded.

Withthepatientinasittingposition,subarachnoid punc-turewasperformedintheL2---L3,L3---L4orL4---L5interspace,

with25Gor27GQuinckeneedles,andthedrugswere

admin-isteredaccordingtothegroupforwhichitwasrandomized.

Local anesthetics and opioids were delivered in separate

syringesforatotaltimeof15s.The patientswere

imme-diatelyplacedinthesupineposition,manuallyshiftingthe uterustotheleftatanangleof15◦.

Blood pressure and heart rate measurements were

recorded before spinal anesthesia and at every 3min in

thefirst15min, andat 30and 45min aftertheblockade.

Hypotension was defined as a decrease in systolic blood

pressure(SBP)upto20%frombaselineandcontrolledwith

intravenous ephedrine (5mg). Bradycardia, defined as a

heartratebelow80%ofbaselineorbelow50bpmof

base-linevalue,wastreatedwithintravenousatropine(0.5mg).

Thelevelofsensoryblockat T6dermatomewastestedat

5,10,and15minaftertheblockadebypinprickwitha22G

needle.

Symptomsoradverseevents,suchasnausea,vomiting,

drowsiness, pain above three on the Visual Analog Scale

(VAS>3)orabdominaldiscomfort,inadditiontotheneonate Apgarscoreinthefirstandfifthminute,needtouse

vaso-pressor for hypotension treatment, fetal extraction time,

anddurationofsurgerywererecorded.Abdominalpainor

discomfortduring surgerywastreated withfentanyl bolus

dosesof50␮g,repeatedattheassistant physician

discre-tion.

Postoperative nausea, vomiting, itching, and pain at

rest (VAS>3) at two, six, and 12h after anesthesiawere recorded.

Statistical analysis was performed using the Epi Info®

7.1.3.0 software. Quantitative variables were analyzed

usingmeanand standard deviation (SD)andsubmitted to

theStudentt-testandthefrequencyofqualitativevariables weresubmittedtothechi-squareandFisherexacttests(the

latterwhentheoccurrenceofvariableswaslessthanfive

andthistestcouldbeperformed).

Results

Intotal, 94patients wereselected andsubmittedto

ran-domization,46patientsinGroupAand48inGroupS.There

weretwolossesinGroup Aduetoinadequatecompletion

ofthequestionnaireandonelossin GroupSdue tospinal

anesthesiatotalfailureandneedforasecondpuncture.

Therewasnostatisticallysignificantdifferencebetween

thetwogroupsregardingageandbodymassindex(BMI)of

patientsandgestationalage(Table1).Themostcommonly

usedpuncturesitewasL3---L4,and27Gneedlewasthemost

usedinbothgroups(Table2).

Themeantimeforfetalextractionwas14.16±4.8min

forGroupAand14.51±4.7minforGroupS,andthemean

durationofsurgerywas56.06±11.75min forGroupAand

57.21±10.88minforGroupS(Table3).

Theuseofephedrinetotreathypotensionwassimilarin

bothgroups(30patientsinGroupAand36patientsinGroup S,68.18%and76.6%,respectively)(Table4).

ThelatencytoreachT6dermatomewassimilarinboth

groups,althoughthenumberofpatientswhoreachedthis

levelin5minwashigherinGroupSthaninGroupA(85.11%

vs. 70.45%), but not statistically significant. Over 90% of

patients achieved this level up to 10min in both groups

(3)

Table1 Characteristicsofpatients.

GroupA(n=44) GroupS(n=47)

Mean SD Mean SD pa

Age(years) 26.0227 6.36 27.34 5.99 0.3114

BMI(kgm−2) 30.64 6.36 32.13 5.43 0.2322

Gestationalage(weeks) 37.9373 2.32 38.31 1.95 0.3976

SD,standarddeviation. aStudent’st-test.

Table2 Spinalpuncturedata.

GroupA GroupS

n=44 % n=47 % pa

Puncturelevel 0.5436

L2---L3 4 9.09% 2 4.26%

L3---L4 37 84.09% 43 91.49%

L4---L5 3 6.82% 2 4.26%

Needle 0.6615

25G 14 31.82% 17 36.17%

27G 30 68.18% 30 63.83%

aChi-squaretest.

Table3 Surgicaltimes.

GroupA(n=44) GroupS(n=47)

Mean SD Mean SD pa

Durationofbirth(min) 14.16 4.8 14.51 4.7 0.7252

Durationofsurgery(min) 56.06 11.75 57.21 10.88 0.6307

aStudent’st-test.

Intraoperativeincidenceofpruritusanddrowsinesswas

higherinGroupS(36.17%and23.4%)thaninGroupA(4.55%

and0%,respectively).

TherewasagreatertendencyofbradycardiainGroupS

(59.57%)thaninGroupA(43.18%),butthisdifferencewas

notstatisticallysignificant.

Therewasnosignificantdifferencebetweengroupsinthe

incidenceofhypotension,nausea,vomiting,decreased

oxy-gensaturationbyhemoglobin(SpO2),abdominaldiscomfort,

andintraoperativepain(Table6).

Table4 Intraoperativeneedofephedrine.a

GroupA(n=44) GroupS(n=47)

n % n %

Yes 30 68.18 36 76.6

No 14 31.82 11 23.4

ap=0.8074;chi-square.

TherewasnosignificantdifferencebetweenApgarscores

atoneand5min,95.45%ofnewbornsinGroupAand95.75%

ofnewbornsinGroupShadscoresbetween7and10at1min

andallinfantshadscorebetween7and10at5min(Table7). Postoperativeevaluation(Table8)showedahigher

inci-dence of pruritus 2h after intrathecal injection in Group

ScomparedtoGroupA(61.7%vs.30.23%,respectively),a

statisticallysignificantdifference.Therewasnosignificant

difference in the incidenceof pruritus duringrevaluation

Table5 LatencytimeofsensoryblocktoreachT6.a GroupA

(n=44)

GroupS (n=47)

n % n %

Upto5min 31 70.45 40 85.11

6---10min 9 20.45 3 6.38

11---15min 1 2.27 3 6.38

(4)

Table6 Intraoperativecomplications.

GroupA(n=44) GroupS(n=47)

n % n % p

Hypotension 36 81.82 37 78.72 0.7111a

Bradycardia 19 43.18 28 59.57 0.1178a

Nausea 17 38.64 16 34.04 0.6487a

Vomiting 9 20.45 6 12.77 0.3232a

Pruritus 2 4.55 17 36.17 c0.0001b

SpO2<95% 3 6.82 1 2.13 0.3504b

Drowsiness 0 0 11 23.4 c0.0005b

Abdominaldiscomfort 5 11.36 1 2.13 0.1032b

Pain 1 2.27 1 2.13 1.0b

a Chi-square. b Fisher’sexact. c p<0.05.

Table7 Apgarscores.

Valor Apgar,1mina Apgar,5minb

GroupA(n=44) GroupS(n=47) GroupA(n=44) GroupS(n=47)

n % n % n % n %

<7 2 4.55 2 4.26 --- --- ---

---7---10 48 95.45 45 95.74 44 100 47 100

a p=0.6663;Fisher’sexact. b p=1;Chi-square

timesatsixand12h,aswellastheincidenceofnauseaand vomitingin alltimes(2, 6,and12h). Ofthefivepatients

whoexperiencedepisodesof vomitingin thereevaluation

after2h,onlyonepersistedwithvomitinginthe2nd

reval-uation(6h).Theotherfouroccurrencesintherevaluation

at6hcorrespondedtonewcases.

Regardingtheoccurrenceofpainatrest(VAS>3),there

wasahigherincidenceinGroup AcomparedtoGroupSin

therevaluationat6haftertheprocedure(18.18%vs.6.38%, respectively),butstatisticallynotsignificant.Theincidence ofpain(VAS>3)12hafter spinalanesthesia tendedtobe similarbetweengroups(Table9).

Table8 Postoperativesideeffects.

GroupA(n=44) GroupS(n=47) p

n % n %

Pruritus

After2hc 13 30.23 29 61.7 0.0027a,c

After6h 13 30.23 18 38.3 0.4212a

After12h 6 13.95 8 17.02 0.6883a

Nausea

After2h 5 11.63 5 12.77 0.8692a

After6h 3 6.98 4 8.51 0.5502b

After12h 4 9.3 1 2.13 0.1538b

Vomiting

After2h 1 2.33 4 8.51 0.2094b

After6h 1 2.33 4 8.51 0.2094b

After12h 0 0 0 0

(5)

Table9 Postoperativepainatrest(VAS>3).

GroupA(n=44) GroupS(n=47) p

n % n %

After2h 3 6.82 4 8.51 0.5372b

After6h 8 18.18 3 6.38 0.0795b

After12h 13 29.55 13 27.66 0.0396a,c

aChi-square. b Fisher’sexact. c p<0.05.

Discussion

To obtain adequate anesthesia for C-section, an intense

blockadecovering fromthe sacral (S2---S4) tothe visceral

fibers(T4---T12)is needed.Ablockadewithsuchextension

resultsinhypotensionbyblockingthesympatheticfibers.10

Thelocalanestheticcommonlyusedis0.5%hyperbaric

bupi-vacaineatdosesrangingfrom7.5to15mg.Theuseof10mg

aloneor 8mg combinedwith opioidsis reported as‘‘low

dose’’bysomeauthors,10whileothersconsider‘‘lowdose’’

onlywhenthebupivacainemassdoesnotexceed8mg.3

Althoughtheliteratureshowatrendtowardbupivacaine

dosereduction uptodosesaslow as8mg,either withor

withouttheadditionoflipophilicopioids,reducingthisdose

tolevelsbelow 10mgwithout epidural catheterinsertion

maybeunsafeduetothepotentialriskoffailurein

obtain-inganadequate levelofblockadeor inadequateblockade

duration for surgical time, which increases the need for

intravenousanalgesicagents(fentanyl)orconversionto gen-eralanesthesia.3,8,9

Higherincidenceofintraoperativehypertensionhasbeen

was reported in patients receiving intrathecal sufentanil

at a dose of 5␮g.17 Other studies of sufentanil at doses

ranging from2.5 to 10␮g failedto establish a significant

relationshipbetweentheuseofintrathecalsufentaniland

hypotension,3,4,15,19 aresultsimilartothatobservedinour

study.However, it is possible that the addition of

sufen-tanilisresponsibleforthenon-occurrenceoftheexpected

decreasein the incidenceof hypotensionwith the

hyper-baricbupivacainedosereducedfrom12.5to10mg.

Althoughtherewasahigherincidenceofbradycardiain

patients whoreceived sufentanil, this differencewasnot

statisticallysignificant. Thisrelationship wasnotobserved previouslyinastudythatevaluatedtheincidenceof brady-cardiainpatientsreceivingsufentanil(10␮g)ormorphine

(200␮g)bythesamerouteofadministration.15

Severalstudieshaveshownthatintrathecalsufentanilis

relatedtosedation15,17,19andthatsufentanilismore

sedat-ingthanspinalmorphine(30%vs.5%,respectively).15These

resultscoincide with thoseobserved by us,asdrowsiness

occurredin23.4%ofpatientsreceivingsufentanilandwas

absentinthegroupthatreceivedonlymorphineasan

adju-vant.

Astudycomparingdifferentdosesofbupivacainealone

forC-sectionunderspinalanesthesiareported35%incidence

ofintraoperativepainwithadoseof8mg,20%withadose

of10mg,andabsent withadose of 12mg.9 We found no

differencesintheoccurrenceofthiseffectwhencomparing

hyperbaricbupivacaine(12.5mg)combinedwithonly

mor-phine withhyperbaric bupivacaine (10mg)combinedwith

morphine and sufentanil. It is probable that the addition

of sufentanil is responsible for maintaining the quality of

analgesiawitha dose reduction,which isin line withthe

resultsobservedinotherstudiesshownthattheadditionof

lipophilicopioiddrasticallyreducestheoccurrenceof

intra-operativepainwhenbupivacaineisusedatdosesbetween

8and10mg.3,9,20

Whentheincidenceofprurituswascomparedbetween

patients who received intrathecal bupivacaine alone and

patients who received sufentanil (10␮g) or morphine

(200␮g)combinedwithbupivacaine,it wasobserved that

theincidencewassignificantlyhigherinpatientsreceiving

sufentanil comparedtothosereceivingmorphine(30% vs.

10%,respectively).15Itwasalsoshownthatpruritusresulting

fromthe use of intrathecal sufentanil is dose-dependent,

rangingfrom34.3%withadoseof2.5␮gto68.6%withadose

of 5␮g.17 Pruritusinducedby intrathecalmorphine isalso

dose-dependent,especiallyindosesabove0.1mg.21Inour

study,asignificantlyhigherdifferenceinprurituswasseen inpatientsreceivingsufentanil,intheintraoperativeperiod

andatthefirstassessment2hafteranesthesia,sufentanil

actionperiod.

Thus,in thepresent study,thedose reduction of 0.5%

hyperbaric bupivacaine from 12.5 10mg, combined with

sufentanil(5␮g)at thelowestdose, maintainedthesame

qualityofanesthesia, butdidnotreduce theincidenceof

hypotension and increased the incidence of pruritus and

sedation.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

References

1.BirnbachDJ, BrowneIM.Anesthesia for obstetrics.In: Miller RD,FleisherLA,Wiener-KronishJP,YoungWL,editors.Miller’s anesthesia,vol.2,7thed.Philadelphia: Churchill-Livingstone-Elsevier;2010.p.2219---20.

(6)

4.RoofthooftE,VandeVeldeM.Low-dosespinalanaesthesiafor caesareansectiontopreventspinal-inducedhypotension.Curr OpinAnaesthesiol.2008;21:259---62.

5.Chinachoti T, Tritakarn T. Prospective study of hypotension and bradycardia during spinal anesthesia with bupivacaine: incidence and risk factors, part two. J Med Assoc Thai. 2007;90:492---501.

6.CynaAM, Andrew M,Emmett RS, et al. Techniquesfor pre-ventinghypotension duringspinal anaesthesiafor caesarean section.CochraneDatabaseSystRev.2006,http://dx.doi.org/ 10.1002/14651858.CD002251.pub3.ANCD002251.

7.VercauterenMP,Coppejans HC, HoffmannVH, et al. Preven-tionof hypotension bysingle5mg dose ofephedrine during smalldosespinalanesthesiainprehydratedcesareandelivery patients.AnesthAnalg.2000;90:324---7.

8.Fan SZ, Susetio L, Wang YP, et al. Low dose ofintrathecal hyperbaricbupivacainecombined withepidurallidocainefor cesareansection--- abalanceblocktechnique.AnesthAnalg. 1994;78:474---8.

9.ChoiDH,AhnHJ,KimMH.Bupivacaine-sparingeffectoffentanyl inspinalanesthesiaforcesareandelivery.RegAnesthPainMed. 2000;25:240---5.

10.DyerRA,JoubertIA.Low-dosespinalanaesthesiaforcaesarean section.CurrOpinAnaesthesiol.2004;17:301---8.

11.CrowhurstJA,BirnbachDJ.Small-doseneuraxialblock:heading towardthenewmillennium.AnesthAnalg.2000;90:241---2. 12.Ben DB, Miller G, Gavriel R, et al. Low dose

bupivacaine-fentanylspinalanesthesiaforcesareandelivery.RegAnesthPain Med.2000;25:235---9.

13.ChoiDH,AhnHJ,KimJA.Combinedlow-dosespinal-epidural anesthesia versus single shot spinal anesthesia for elective cesareandelivery.IntJObstetAnesth.2006;15:13---7.

14.GhaziA,RajaY.Combinedlow-dosespinal---epidural anaesthe-siaversussingle-shotspinalanaesthesiaforelectivecaesarean delivery.IntJObstetAnesth.2007;16:90---1.

15.VeenaA,AmitA,JagdishSP,etal.Comparisonofintrathecal sufentanil and morphine inaddition to bupivacaine for cae-sareansectionunderspinalanesthesia.AnaesthPainIntensive Care.2010;14:99---101.

16.DahlgrenG,HultstrandC,JakobssonJ,etal.Intrathecal sufen-tanil,fentanyl,orplaceboaddedtobupivacaineforcesarean section.AnesthAnalg.1997;85:1288---93.

17.Bang YS, Chung KH, Lee JH, et al. Comparison of clini-cal effects according to the dosage of sufentanil added to 0.5%hyperbaricbupivacainefor spinalanesthesia inpatients undergoing cesareansection.Korean JAnesthesiol. 2012;63: 321---6.

18.Braga AA, Frias JAF, Braga FS, et al. Raquianestesia em operac¸ão cesariana. Emprego da associac¸ão de bupivacaína hiperbárica(10mg)adiferentesadjuvantes.RevBras Aneste-siol.2012;62:775---87.

19.LeeJH,ChungKH,LeeJY,etal.Comparisonoffentanyland sufentanil added to 0.5% hyperbaric bupivacaine for spinal anesthesia inpatientsundergoingcesareansection.KoreanJ Anesthesiol.2011;60:103---8.

20.BograJ,AroraN,SrivastavaP.Synergisticeffectof intrathe-calfentanylandbupivacaineinspinalanesthesiaforcesarean section.BMCAnesthesiol.2005;5:5.

Imagem

Table 5 Latency time of sensory block to reach T6. a Group A (n = 44) Group S(n=47) n % n % Up to 5 min 31 70.45 40 85.11 6---10 min 9 20.45 3 6.38 11---15 min 1 2.27 3 6.38
Table 6 Intraoperative complications. Group A (n = 44) Group S (n = 47) n % n % p Hypotension 36 81.82 37 78.72 0.7111 a Bradycardia 19 43.18 28 59.57 0.1178 a Nausea 17 38.64 16 34.04 0.6487 a Vomiting 9 20.45 6 12.77 0.3232 a Pruritus 2 4.55 17 36.17 c 0
Table 9 Postoperative pain at rest (VAS &gt; 3). Group A (n = 44) Group S (n = 47) p n % n % After 2 h 3 6.82 4 8.51 0.5372 b After 6 h 8 18.18 3 6.38 0.0795 b After 12 h 13 29.55 13 27.66 0.0396 a,c a Chi-square

Referências

Documentos relacionados

This was a randomized, double-blind, multicenter (four centers), phase III, parallel clinical trial conducted in Brazil and comparing the efficacy and safety of a fixed-dose,

In the article ‘‘Addition of lidocaine to levobupivacaine reduces intrathecal block duration: randomized controlled trial’’ (estudo clínico randômico’’ (Rev Bras

Letter to the editor: Spinal subarachnoid hematoma after-spinal anesthesia: case report [Rev Bras Anestesiol 2016]. Carta à editora:

Letter to the editor: Spinal subarachnoid hematoma after-spinal anesthesia: case report [Rev Bras Anestesiol 2016].. Carta à editora:

Therefore, the objective of this double-blind randomized clinical trial was to evaluate the influence of pre-treatment with PA on the clinical behavior of etch-and- rinse

Abstract: The objective of this split-mouth, double-blind, randomized controlled trial was to compare the clinical effect of treatment of 2- or 3-wall intrabony

This double-blind, randomized, placebo-controlled clinical trial is the irst study to evaluate the toxicology and safety of tincture of O. alata in patients with

After the antibacterial activity of the experimental dentifrice was confirmed in vitro , was carried out the phase II: a randomized, controlled, double-blind clinical